Stocksigma LogoStocksigma Logo

RPG Life Sciences Acquires Raghava Life's API Business for ₹135 Crore

On 2nd Sep'26, RPG Life Sciences announced its subsidiary RPGAP will acquire Raghava Life Sciences’ API business for up to ₹135 crore via a slump sale

RPG Life Sciences Acquires Raghava Life's API Business for ₹135 Crore

RPG Life Sciences Ltd · Press Release · 03 Sept 2026, 3:53 am

RPG Life Sciences Acquires Raghava Life's API Business for ₹135 Crore On 2nd Sep'26, RPG Life Sciences announced its subsidiary RPGAP will acquire Raghava Life Sciences’ API business for up to ₹135 crore via a slump sale. The deal adds an EU-GMP approved Hyderabad facility with 300 KL capacity, 22 commercialized APIs, and 7 pipeline assets. Following the Actis Generics buyout, this transaction accelerates RPGAP's buy-and-build strategy to bolster its integrated API scale, unlocking backward integration and cost synergies. The acquisition will be funded entirely through RPGAP’s recent equity raise.

Original exchange filing (PDF)

More announcements from RPG Life Sciences Ltd

All RPG Life Sciences Ltd announcements